Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical's (AVNS) quarterly Other Accumulated Expenses came in at $34.1 million in Q3 2018, up 16.78% quarter-over-quarter from $29.2 million in Q4 2017.

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018) Analysis & Trends

Avanos Medical has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $34.1 million for Q3 2018.

  • Other Accumulated Expenses for Q3 2018 came in at $34.1 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $34.1 million (changed N/A YoY), and the FY2017 annual result was $29.2 million, changed N/A from the prior year.
  • Other Accumulated Expenses came in at $34.1 million for Q3 2018 at Avanos Medical, up from $29.2 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $34.1 million in Q3 2018 to a low of $29.2 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Avanos Medical 1.16 Bn 1.09 Bn 94.20 Mn

Historic Data

Download Data
DateValue
Sep 30, 2018 34.10 Mn
Dec 31, 2017 29.20 Mn